Minerva Neurosciences, Inc. (NERV): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-8, first reflected in a filing dated 2022-08-09. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

43.27M
As of 2025-12-31
47.23M
As of 2026-06-30
+100.9%
3-year compound annual growth
2013-12-31: 6.11M2014-12-31: 18.44M2015-12-31: 24.72M2016-12-31: 35.02M2017-12-31: 38.75M2018-12-31: 38.94M2019-12-31: 39.08M2020-12-31: 42.72M2021-12-31: 5.34M2022-12-31: 5.34M2023-12-31: 6.99M2024-12-31: 6.99M2025-12-31: 43.27M43.27M
2013-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2025-12-3143.27M+518.8%2026-03-11, Balance as of period end
2024-12-316.99M0.0%2026-03-11, Balance as of period end
2023-12-316.99M+31.0%2025-02-25, Balance as of period end
2022-12-315.34M0.0%2024-02-22, Balance as of period end
2021-12-315.34Mn/c2023-03-08, Balance as of period end
2020-12-3142.72M+9.3%2022-03-01, Balance as of period end
2019-12-3139.08M+0.4%2021-03-08, Balance as of period end
2018-12-3138.94M+0.5%2020-03-09, Balance as of period end
2017-12-3138.75M+10.6%2019-03-12, Balance as of period end
2016-12-3135.02M+41.7%2018-03-12, Balance as of period end
2015-12-3124.72M+34.1%2017-03-13, Balance as of period end
2014-12-3118.44Mn/c2016-03-14, Balance as of period end
2013-12-316.11Mn/a2015-03-26, Balance as of period end